SOURCE: Implant Sciences

Implant Sciences

May 18, 2011 07:00 ET

Implant Sciences Receives $586,000 Order for Quantum Sniffer Units to Be Deployed at 2011 Summer Universiade

WILMINGTON, MA--(Marketwire - May 18, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has received a new order valued at over $586,000 to supply Quantum Sniffer™ QS-H150 systems for security screening at the 2011 Summer Universiade in Shenzhen, China.

The Universiade, also known as the World University Games, is an international multi-sport event, organized for university athletes by the International University Sports Federation. This year's event will take place in the southern Chinese city of Shenzhen, Guangdong Province, from August 12th to August 22nd. Shenzhen, located directly north of Hong Kong, is a busy port and one of the fastest growing cities in the world.

"The Quantum Sniffer has a distinguished history for providing security in China, including the 2008 Summer Olympics, Civil Aviation Authority of China, and several railway and subway systems. Out of necessity, high profile sporting events such as the 2011 Summer Universiade are incorporating explosives trace detection into their security procedures. Our ability to continue to win orders for such high profile events is a testament to the effectiveness and reliability of our products," stated Implant Sciences' CEO, Glenn D. Bolduc.

About the Quantum Sniffer QS-H150
The QS-H150 Quantum Sniffer is a hand-held explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, and homemade explosives. The QS-H150 features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability and extremely low total cost of ownership.

About the Quantum Sniffer QS-B220
The Quantum Sniffer QS-B220, launched in May 2011, is a bench-top explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, improvised, or homemade explosives and narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 Portable Explosives Detector has been designated as Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at

Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by governments or by other law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:
    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    Email Contact


    Investor Contact:
    Laurel Moody
    Email Contact